Jean-Philippe COURADE

En résumé

Entreprises

• Pfizer

  Paris maintenant

• UCB - Director, CNS project leader

  COLOMBES 2009 - maintenant Project leader in neurodegeneration (Parkinson's disease, Alzheimer's disease), Epilepsy.
  Ensure smooth cross discipline work to progress projects from target ID to clinical candidate nomination. Set-up external collaborations (Universities, CROs).
  Present the project plans, budget and resource request to stakeholder committees, and scientific advisory board.
  Assessment of in licensing opportunities (due diligence). Writing different sections of Investigator's Brochure. Writing different sections and coordination of patent applications.
  
  Formerly (2009-2011) department leader (pharmacology Pain & Migraine, UCB, Belgium). Managing 5FTE in the in vivo pharmacology Pain and Migraine therapeutic areas. Pain Strategy Team. Novel drug targets. Project champion. Initiate external collaborations to develop new animal models and identify predictive biomarkers.

• Pfizer - Principal Scientist

  Paris 2005 - 2009 Chronic pain Therapeutic area (Pfizer, UK). - Biology Project leader, international project. Provides single point of accountability to Project Leader for delivering biology aspects of a project from lead compound to first in human. Provides scientific expertise to recommend experimental strategies to project leader, Responsible for putting into place the biomarker strategy and translational research plan. Ensures optimal resourcing for project biology. Ensures high quality biological data is provided to the project. Presents and justifies project biology to key stakeholders, internally and externally. Liaise with international (US, Germany) external and internal partners. Management of 2 FTE and 2 PhD CASE student. Set up external collaboration (SCRIPPS, CASE students). Lab work: wet Biomarker research, neurotransmitter release from spinal cord slices.

• Novartis - Scientist

  RUEIL MALMAISON 2001 - 2004 Chronic pain Therapeutic area (Novartis, UK). Behavioural Pharmacologist. New target validation, development of in vivo models, in vivo assessment of drug candidates for pain therapeutics (neuropathic, inflammatory, safety models), surgery (CCI, telemetry CV, bone cancer pain) reporting and coordination of reports, training.

Formations

• Faculté De Médecine De Clermont Ferrand. Université D'Auvergne. Clermont-1

  Clermont Ferrand 1998 - 2001 PhD Neuropharmacology
  
  CIFRE Contract (PhD in a pharmaceutical company: UPSA laboratories (Bristol-Myers Squibb group, Rueil-Malmaison, France)), first honours (`mention très honorable avec les félicitations du jury'). Thesis: Central antinociceptive action of acetaminophen: from diffusion to target. Techniques: in vitro (HPLC, enzyme assays, gene expression macroarray) and in vivo (inflammatory and neuropathic behaviou

• Faculté De Médecine Université Paris Sud (XI)

  Kremlin Bicêtre 1996 - 1997 Master (DEA) Experimental and Clinical Pharmacology
  
  Thesis: Interactions between opioidergic and cholecystokininergic systems in the spinal cord. In vitro study in normal and morphine-tolerant rats. Supervisor: Dr. M. Hamon.

• Université Pierre Et Marie Curie (Paris VI)

  Paris 1995 - 1996 Bachelor of Science (Maîtrise) biochemistry
  
  biochemistry, organic chemistry, neurobiology

Réseau

• Alice TÉTU

• Brice CAMPO

• Christelle LAURET

• Edouard GUILLABERT

• Fabrice ROSSI

• Jean STEINFORT

• Laurent HACHE

• Michel HAMON

• Quere PASCAL

• Stephane NION